Chao Li

机构：Eli Lilly (United States), First Affiliated Hospital of Xi'an Jiaotong University, Shandong First Medical University, China Medical University · ORCID：0000-0001-5723-1414

发表论文 167 篇 · 总被引 3866 次 · h-index 35

代表论文

• An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer (2025 · Cell stem cell · 被引 38)
• Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE (2025 · American Journal of Ophthalmology · 被引 20)
• Renal tubular epithelial IGFBP7 interacts with PKM2 to drive renal lipid accumulation and fibrosis (2025 · Molecular Therapy · 被引 18)
• Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension Study (2025 · Ophthalmic surgery, lasers & imaging retina · 被引 11)
• Outer membrane vesicle–coated ferrocene nanoparticles induce dual ferroptosis for cancer immunotherapy (2025 · Journal of Controlled Release · 被引 10)
• Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis (2025 · Dermatology and Therapy · 被引 9)